Invesaro

Stocks Comparison

Outset Medical vs TransMedics: revenue, profit, margins and growth compared

Outset Medical brought in $119.5M of revenue in fiscal 2025, TransMedics $605.5M in fiscal 2025. Revenue changed by +5.1% at Outset Medical and +37.1% at TransMedics on the year before, so TransMedics grew faster. Outset Medical kept -68.3% of its revenue as net profit, TransMedics 31.4%. Free cash flow was -$47.1M at Outset Medical and $133.6M at TransMedics.

Side by side, latest fiscal year

OMTMDX
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$119.5M$605.5M
Revenue growth+5.1%+37.1%
Net income-$81.7M$190.3M
Net margin-68.3%31.4%
Free cash flow-$47.1M$133.6M
Free cash flow margin-39.4%22.1%
Earnings per share (diluted)-$5.37$4.87
Cash$35M$488.9M
Debt$96.2M$10M
Price to earningsn/a17.5
Market value$57.3M$3B
Dividend yieldn/an/a
Rank by revenue in sector#287 of 523 · Health care#182 of 523 · Health care

Over the years

Revenue
OM FY2018: $2MOM FY2020: $15.1MOM FY2020: $49.9MOM FY2021: $102.6MOM FY2022: $115.4MOM FY2023: $130.4MOM FY2024: $113.7MOM FY2025: $119.5MTMDX FY2019: $14.7MTMDX FY2019: $25.8MTMDX FY2020: $28.4MTMDX FY2021: $31.4MTMDX FY2022: $93.5MTMDX FY2023: $241.6MTMDX FY2024: $441.5MTMDX FY2025: $605.5MFY18FY19FY20FY21FY22FY23FY24FY25
OM $119.5MTMDX $605.5M
Net income
OM FY2018: -$49.8MOM FY2020: -$68.3MOM FY2020: -$121.5MOM FY2021: -$131.9MOM FY2022: -$163MOM FY2023: -$172.8MOM FY2024: -$128MOM FY2025: -$81.7MTMDX FY2019: -$23.8MTMDX FY2019: -$33.5MTMDX FY2020: -$28.7MTMDX FY2021: -$44.2MTMDX FY2022: -$36.2MTMDX FY2023: -$25MTMDX FY2024: $35.5MTMDX FY2025: $190.3MFY18FY19FY20FY21FY22FY23FY24FY25
OM -$81.7MTMDX $190.3M
Net margin
OM FY2018: -2,480.3%OM FY2020: -453.0%OM FY2020: -243.3%OM FY2021: -128.6%OM FY2022: -141.2%OM FY2023: -132.5%OM FY2024: -112.6%OM FY2025: -68.3%TMDX FY2019: -162.1%TMDX FY2019: -129.8%TMDX FY2020: -101.4%TMDX FY2021: -140.9%TMDX FY2022: -38.8%TMDX FY2023: -10.4%TMDX FY2024: 8.0%TMDX FY2025: 31.4%FY18FY19FY20FY21FY22FY23FY24FY25
OM -68.3%TMDX 31.4%
Revenue growth
OM FY2020: +651.3%OM FY2020: +231.2%OM FY2021: +105.5%OM FY2022: +12.4%OM FY2023: +13.0%OM FY2024: -12.8%OM FY2025: +5.1%TMDX FY2019: +76.3%TMDX FY2020: +9.7%TMDX FY2021: +10.7%TMDX FY2022: +197.8%TMDX FY2023: +158.5%TMDX FY2024: +82.7%TMDX FY2025: +37.1%FY19FY20FY21FY22FY23FY24FY25
OM +5.1%TMDX +37.1%
Free cash flow
OM FY2018: -$48.2MOM FY2020: -$73.6MOM FY2020: -$108.1MOM FY2021: -$133.4MOM FY2022: -$154.1MOM FY2023: -$134.8MOM FY2024: -$117.2MOM FY2025: -$47.1MTMDX FY2019: -$26.4MTMDX FY2019: -$32.5MTMDX FY2020: -$30.7MTMDX FY2021: -$32.4MTMDX FY2022: -$57.7MTMDX FY2023: -$164.9MTMDX FY2024: -$80.9MTMDX FY2025: $133.6MFY18FY19FY20FY21FY22FY23FY24FY25
OM -$47.1MTMDX $133.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about Outset Medical and TransMedics

Which is bigger by revenue, Outset Medical or TransMedics?

TransMedics is bigger by revenue: $605.5M in fiscal 2025, against $119.5M for Outset Medical in fiscal 2025.

Which keeps more of its revenue as profit, Outset Medical or TransMedics?

Outset Medical had a net margin of -68.3% in fiscal 2025; TransMedics had 31.4% in fiscal 2025.

Which grew revenue faster, Outset Medical or TransMedics?

In their latest fiscal years revenue changed by +5.1% at Outset Medical and +37.1% at TransMedics.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies